163
They also echo a truth that we repeat every issue and this is straight off of their site:
Unfortunately, it also enabled low quality stocks to entice investors, by claiming large potential gains in a short period of time. The inexperienced were naturally drawn to these potential gains, but instead found significant losses on their investment as these companies and individuals took advantage of them.
Does this not sound familiar? Again, third party after the fact validation of our own hypothesis of the real threat to retail investors by the unscrupulous.
We introduced you to Delivra Corp (TSXV:DVA) several months ago and DVA is included in a few strategies such as our companies with growing revenues but low market cap (share price) and diversified. DVA has not disappointed with its share price recently $0.52 at time of writing. DeepDive.ca just published a detailed and current report. The title of their report is a bid unfair (the cannabis company you’ve never heard) because our many subscribers have indeed heard of this Cannabis industry company and months before the typical retail investor did. In fact, if you buy the #1 selling nerve pain relief cream in Canada then you indeed know this company. Their breakthrough came in late 2016 with a topical version of Celebrex™ (celecoxib).
DVA is a good example of a company that does not pay the stock promoters because the usuals have rarely to never mentioned
DVA and its volume is too high most days for the
social media and bulletin board boiler rooms to work
their craft. At its current market cap and growing
revenues, this remains a hidden gem in this industry.
CHV, TNY, and DVA are good examples as to why
DeepDive has made my valid third party site list.
DVA just may be our gift to you - time will tell.